Best of June: Top 5 Insights In Clinical Supply Chain & Logistics

#1 - New Guide Tackles Best Practices For Making Allogeneic Cell Therapies

The ISPE sought to accelerate guideline development for allogeneic cell therapy. This discussion digs into some of the bigger themes in its recent guide.

#2 - Safeguarding Cell Therapy Cryopreservation: Primary Container Considerations

Review different aspects of container selection from the perspective of cryopreservation that are may be overlooked but critical for the quality of cell therapy drug products.

#3 - Digitalized Drug Forecasting Minimizes Waste In Clinical Trial Supply Chain

Why should pharma companies strive for more sustainable clinical trials? And how can digitalizing drug forecasting reduce waste in the supply chain? J&J Innovative Medicine's Kristel Rens explains.

#4 - Providing Drug Supply Support In Complex Environments Through IRT

Learn how applying predictive data analytics can enable the creation of an ideal supply strategy capable of reducing the need for extra shipments, manual oversight, and supply waste.

#5 - FDA's Draft Guidance On Safety Testing Of Human Allogeneic Cells For Use In Cell-Based Therapies

This article provides a summary and analysis of the FDA's new draft guidance, Safety Testing of Human Allogeneic Cells Expanded for Use in Cell-Based Medical Products.